Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Improving Clinical Trials Reporting

Project description

Strategies to combat research waste in clinical trials

The non-publication of clinical trial results wastes an estimated $85 billion annually in medical research funding and skews the evidence since negative findings are often unreported. This can lead to costly errors in healthcare. While safeguards in clinical trials have improved, the effectiveness of measures to combat research waste remains largely unstudied. Supported by the Marie Skłodowska-Curie Actions programme, the ICTR project will evaluate three strategies to reduce research waste and publication bias in clinical trials. Its findings will enhance the reliability of scientific evidence in both natural and social sciences. The project will determine which methods effectively minimise research waste.

Objective

This proposal will rigorously evaluate three approaches to reducing research waste and publication bias in clinical trials. The findings will provide a firm evidence base to inform efforts to improve the robustness of scientific evidence across the natural and social sciences.

Non-publication of results has been estimated to directly waste $85 billion per year in medical research funding. Gaps left by unreported clinical trial results systematically distort the scientific evidence base because negative findings are especially likely to remain unreported.
Health systems and insurers are often unable to determine how safe, effective and cost-effective treatments really are, leading to costly procurement missteps and suboptimal and sometimes dangerous patient care. For example, governments worldwide spent over $18 billion on the drug Tamiflu before the previously hidden results of several unsuccessful clinical trials emerged.

Today, research waste safeguards for clinical trials are stronger and more advanced than in any other area of research. Multiple approaches to tackling the twin problems of research waste and publication bias have been pioneered in the clinical trials space and are now being adopted in other branches of science.

However, it remains unclear which of these measures are effective because their impact has rarely been studied in a systematic and rigorous manner. This undermines efforts to improve the robustness of research across the natural and social sciences.

This proposal will fill an important knowledge gap by providing robust evidence on which approaches to reducing research waste and curbing publication bias are effective. Breaking new methodological ground, it will answer three questions:

Can stronger funder safeguards reduce research waste?
Can sending reminder messages to research institutions reduce research waste?
What reminder messages to principal investigators reduce research waste most?

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2023-PF-01

See all projects funded under this call

Coordinator

KAROLINSKA INSTITUTET
Net EU contribution
€ 206 887,68
Address
NOBELS VAG 5
171 77 STOCKHOLM
Sweden
Region
Östra Sverige Stockholm Stockholms län
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Partners (1)